美国 · SEC FORM 4
RESMED INC
RMD · NYSE; OTC · CIK 0000943819 · Healthcare · Medical Instruments & Supplies
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
19 同一窗口内观察到的 Form 4 交易行
8 sales · 11 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
—
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot.—
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 12,783,009
- 上期报告
- 14,203,907
- 日均成交量
- 1,294,339
- 回补天数
- 9.9
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
本地 Form 4 历史中没有合资格的代码 P 股票买入。
Form 4 申报证据
76 transaction lines in the latest 365-day window; 723 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-07 | Farrell Michael J. | 卖出 (S) | ResMed Common Stock | 4,991 | USD 226.33 | USD 1,129,637 | SEC 申报 ↗ |
| 2026-10-07 | Farrell Michael J. | 期权行权／转换 (M) | ResMed Common Stock | 4,991 | USD 146.34 | USD 730,383 | SEC 申报 ↗ |
| 2026-09-08 | Farrell Michael J. | 卖出 (S) | ResMed Common Stock | 4,991 | USD 222.44 | USD 1,110,198 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-07 | Farrell Michael J. | 卖出 (S) | ResMed Common Stock | 4,991 | USD 226.33 | USD 1,129,637 | SEC 申报 ↗ |
| 2026-10-07 | Farrell Michael J. | 期权行权／转换 (M) | ResMed Common Stock | 4,991 | USD 146.34 | USD 730,383 | SEC 申报 ↗ |
| 2026-09-08 | Farrell Michael J. | 卖出 (S) | ResMed Common Stock | 4,991 | USD 222.44 | USD 1,110,198 | SEC 申报 ↗ |
| 2026-09-08 | Farrell Michael J. | 期权行权／转换 (M) | ResMed Common Stock | 4,991 | USD 146.34 | USD 730,383 | SEC 申报 ↗ |
| 2026-09-02 | FARRELL PETER C | 卖出 (S) | ResMed Common Stock | 970 | USD 234.73 | USD 227,688 | SEC 申报 ↗ |
| 2026-08-14 | Rider Michael J | 奖励／授予 (A) | ResMed Common Stock | 3,230 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-14 | Leong Justin | 奖励／授予 (A) | ResMed Common Stock | 6,461 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-14 | Farrell Michael J. | 奖励／授予 (A) | ResMed Common Stock | 13,547 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-14 | Bloomer Aaron | 奖励／授予 (A) | ResMed Common Stock | 9,072 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-07 | Farrell Michael J. | 卖出 (S) | ResMed Common Stock | 4,991 | USD 205.69 | USD 1,026,599 | SEC 申报 ↗ |
| 2026-08-07 | Farrell Michael J. | 期权行权／转换 (M) | ResMed Common Stock | 4,991 | USD 146.34 | USD 730,383 | SEC 申报 ↗ |
| 2026-08-05 | FARRELL PETER C | 卖出 (S) | ResMed Common Stock | 8,000 | USD 225.00 | USD 1,800,000 | SEC 申报 ↗ |
| 2026-07-07 | Farrell Michael J. | 卖出 (S) | ResMed Common Stock | 4,991 | USD 218.55 | USD 1,090,783 | SEC 申报 ↗ |
| 2026-07-07 | Farrell Michael J. | 期权行权／转换 (M) | ResMed Common Stock | 4,991 | USD 146.34 | USD 730,383 | SEC 申报 ↗ |
| 2026-06-08 | Farrell Michael J. | 卖出 (S) | ResMed Common Stock | 4,991 | USD 193.96 | USD 968,054 | SEC 申报 ↗ |
| 2026-06-08 | Farrell Michael J. | 期权行权／转换 (M) | ResMed Common Stock | 4,991 | USD 146.34 | USD 730,383 | SEC 申报 ↗ |
| 2026-06-01 | Rider Michael J | 代扣税 (F) | ResMed Common Stock | 269 | USD 190.57 | USD 51,214 | SEC 申报 ↗ |
| 2026-05-07 | Farrell Michael J. | 卖出 (S) | ResMed Common Stock | 4,991 | USD 207.82 | USD 1,037,230 | SEC 申报 ↗ |
| 2026-05-07 | Farrell Michael J. | 期权行权／转换 (M) | ResMed Common Stock | 4,991 | USD 146.34 | USD 730,383 | SEC 申报 ↗ |
| 2026-04-07 | Farrell Michael J. | 卖出 (S) | ResMed Common Stock | 4,991 | USD 225.50 | USD 1,125,470 | SEC 申报 ↗ |
| 2026-04-07 | Farrell Michael J. | 期权行权／转换 (M) | ResMed Common Stock | 4,991 | USD 146.34 | USD 730,383 | SEC 申报 ↗ |
| 2026-04-01 | Sandercock Brett | 卖出 (S) | ResMed Common Stock | 1,000 | USD 224.31 | USD 224,310 | SEC 申报 ↗ |
| 2026-04-01 | FARRELL PETER C | 卖出 (S) | ResMed Common Stock | 2,000 | USD 225.00 | USD 450,000 | SEC 申报 ↗ |
| 2026-03-09 | Farrell Michael J. | 卖出 (S) | ResMed Common Stock | 4,991 | USD 251.03 | USD 1,252,891 | SEC 申报 ↗ |
| 2026-03-09 | Farrell Michael J. | 期权行权／转换 (M) | ResMed Common Stock | 4,991 | USD 146.34 | USD 730,383 | SEC 申报 ↗ |
| 2026-03-04 | FARRELL PETER C | 卖出 (S) | ResMed Common Stock | 2,000 | USD 260.22 | USD 520,440 | SEC 申报 ↗ |
| 2026-03-02 | Sandercock Brett | 卖出 (S) | ResMed Common Stock | 1,000 | USD 254.30 | USD 254,300 | SEC 申报 ↗ |
| 2026-02-09 | Farrell Michael J. | 卖出 (S) | ResMed Common Stock | 4,991 | USD 273.78 | USD 1,366,436 | SEC 申报 ↗ |
| 2026-02-09 | Farrell Michael J. | 期权行权／转换 (M) | ResMed Common Stock | 4,991 | USD 146.34 | USD 730,383 | SEC 申报 ↗ |
| 2026-02-04 | Rider Michael J | 卖出 (S) | ResMed Common Stock | 50 | USD 260.00 | USD 13,000 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | RMD |
| CIK | 0000943819 |
| 行业 | Healthcare |
| 细分行业 | Medical Instruments & Supplies Yahoo Finance |
| SEC SIC | 3841 Surgical & Medical Instruments & Apparatus |
| 交易所 | NYSE; OTC |
数据覆盖
| 本地 Form 4 历史 | 723 transaction lines from 2020-01-02 to 2026-10-07 0 P purchase lines · 319 S sale lines · 404 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.